本页面由Tiger Trade Technology Pte. Ltd.提供服务

Larimar Therapeutics, Inc.

2.16
-0.3700-14.62%
盘后:2.200.0400+1.85%19:17 EDT
成交量:256.79万
成交额:572.24万
市值:2.25亿
市盈率:-1.12
高:2.53
开:2.53
低:2.13
收:2.53
52周最高:6.42
52周最低:2.13
股本:1.04亿
流通股本:5,754.16万
量比:2.82
换手率:4.46%
股息:- -
股息率:- -
每股收益(TTM):-1.9258
每股收益(LYR):-2.2711
净资产收益率:-139.63%
总资产收益率:-70.96%
市净率:1.76
市盈率(LYR):-0.95

数据加载中...

2020/07/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/30

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/26

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/06/26

重要事件披露

8-K/A [Amend] - Current report
2020/06/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/08

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/06/08

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/06/05

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/06/03

重要事件披露

8-K - Current report
2020/06/02

重要事件披露

8-K - Current report
2020/05/07

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/04/27

SEC问询函

CORRESP [Cover] - Correspondence
2020/04/24

重要事件披露

8-K - Current report
2020/04/10

SEC问询函

CORRESP [Cover] - Correspondence
2020/03/09

重要事件披露

8-K - Current report
2020/03/05

重要事件披露

8-K - Current report
2020/03/05

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/03/05

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals